Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. EFFECT Other Notice of Effectiveness
  2. 424B3 Offering Prospectus
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. S-4/A Deal Registration Statement - Business Combination
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-4/A Deal Registration Statement - Business Combination
  7. UPLOAD Other SEC-generated Letter
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-4/A Deal Registration Statement - Business Combination
  10. UPLOAD Other SEC-generated Letter
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 8-K Event Executive or director change
  13. SC 13G Stake Amended Statement of Ownership
  14. 10-Q Report Quarterly Report
  15. S-4 Deal Registration Statement - Business Combination
  16. 8-A12B Other Registration of Securities
  17. 425 Deal Prospectus/Communication re Business Combination
  18. 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Regulation FD disclosure
  19. 10-K/A Report 10-K/A
  20. 8-K Event Material agreement · Agreement ended

Page 15 of 33 · 660 filings